Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adult Laboratory Classroom Study of the Efficacy and Safety of PRC-063 (Extended-Release Methylphenidate) for the Treatment of ADHD

OBJECTIVE: To evaluate the efficacy, safety, and duration of action of the once-daily extended-release methylphenidate formulation PRC-063 for the treatment of ADHD in an adult laboratory classroom (ALC). METHOD: After dose optimization with PRC-063 over 7 weeks, adults with ADHD were randomized to...

Descripción completa

Detalles Bibliográficos
Autores principales: Childress, Ann, Cutler, Andrew J., Marraffino, Andrea H., Bhaskar, Sailaja, Donnelly, Graeme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859679/
https://www.ncbi.nlm.nih.gov/pubmed/34189995
http://dx.doi.org/10.1177/10870547211025610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859679/
https://www.ncbi.nlm.nih.gov/pubmed/34189995
http://dx.doi.org/10.1177/10870547211025610

Ejemplares similares